In vivo experiments combining RT with epidermal growth factor receptor (EGFR)-targeted CAR T cells in triple-negative breast cancer demonstrated synergistic interaction of both modalities mediated via NF-kB-ICAM1 activation [125]. This evidence concerns the gene EGFR and triple-negative breast carcinoma.